Forget about Herceptin. There’s a new HER2 agent that ought to be used in HER2-positive stomach cancer, and that’s Jazz ...
Incyte Corporation rated Buy on surging Hem/Onc growth, Monjuvi/Minjuvi catalysts, frontMIND data and strong cash. Click for ...
In a groundbreaking development, First Ascent Biomedical unveils a compelling narrative of resilience and innovation through ...
Morning Overview on MSN
New discovery could prevent chemo nerve pain that won’t quit
Chemotherapy has long forced patients to choose between fighting their cancer and living with nerve pain that can linger for ...
Hina Khan shares concerning health update, linking her breathing difficulties and constant coughing to the severe air quality ...
Hina Khan is very much affected by the air pollution in Mumbai. She recently shared a picture of Mumbai's Poor Air Quality ...
Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...
A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...
The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...
Syda Segovia Taylor is the founder and executive director of Organic Oneness and a member of the Chicago Reparations Task ...
The following information was released by the office of the Governor of New York:. Reducing Costs for Consumers by Requiring Health Insurers To Cover Medically Necessary EpiPens and Capping ...
A woman who has received a breakthrough gene-editing treatment on the NHS is hoping 2026 is the year she will be cured of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback